BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7556047)

  • 1. Age related changes in biochemical markers of bone metabolism in horses.
    Price JS; Jackson B; Eastell R; Goodship AE; Blumsohn A; Wright I; Stoneham S; Lanyon LE; Russell RG
    Equine Vet J; 1995 May; 27(3):201-7. PubMed ID: 7556047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
    Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
    Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.
    Akimoto S; Akakura K; Shimazaki J
    Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].
    Imai T; Honda M; Maeda S; Hosoya Y; Arai T; Sumi S; Umeda H; Yano M; Koga F; Arai K; Yoshida K
    Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum markers of bone metabolism in dogs.
    Allen MJ; Hoffmann WE; Richardson DC; Breur GJ
    Am J Vet Res; 1998 Mar; 59(3):250-4. PubMed ID: 9522938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W; Muley T; Herb KP; Schmidt-Gayk H
    Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
    Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report.
    Shimozuma K; Sonoo H; Fukunaga M; Ichihara K; Aoyama T; Tanaka K
    Jpn J Clin Oncol; 1999 Jan; 29(1):16-22. PubMed ID: 10073146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy.
    Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Szymańska A; Nahaczewska W
    Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers of bone metabolism in growing thoroughbreds: a longitudinal study.
    Price JS; Jackson BF; Gray JA; Harris PA; Wright IM; Pfeiffer DU; Robins SP; Eastell R; Ricketts SW
    Res Vet Sci; 2001 Aug; 71(1):37-44. PubMed ID: 11666146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis.
    Ostrowska Z; Kos-Kudla B; Swietochowska E; Marek B; Kajdaniuk D; Górski J
    Neuro Endocrinol Lett; 2001 Apr; 22(2):129-36. PubMed ID: 11335889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New markers of bone and collagen turnover in children and adults with growth hormone deficiency.
    Sartorio A; Conti A; Monzani M
    Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response of the skeleton to physical training: a biochemical study in horses.
    Price JS; Jackson B; Eastell R; Wilson AM; Russell RG; Lanyon LE; Goodship AE
    Bone; 1995 Sep; 17(3):221-7. PubMed ID: 8541134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in bone turnover in 2-year-old Thoroughbreds.
    Jackson BF; Lonnell C; Verheyen K; Wood JL; Pfeiffert DU; Price JS
    Equine Vet J; 2003 Nov; 35(7):702-6. PubMed ID: 14649363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of biochemical markers in patients with metabolic bone disorders.
    Hoshino H; Kushida K; Takahashi M; Kawana K; Denda M; Yamazaki K; Inoue T
    Endocr Res; 1998 Feb; 24(1):55-64. PubMed ID: 9553754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle.
    Gorai I; Taguchi Y; Chaki O; Kikuchi R; Nakayama M; Yang BC; Yokota S; Minaguchi H
    J Clin Endocrinol Metab; 1998 Feb; 83(2):326-32. PubMed ID: 9467535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen.
    Brahm H; Ljunggren O; Larsson K; Lindh E; Ljunghall S
    Calcif Tissue Int; 1994 Dec; 55(6):412-6. PubMed ID: 7895178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and traditional serum markers of bone metabolism in the detection of skeletal metastases.
    Plebani M; Bernardi D; Zaninotto M; De Paoli M; Secchiero S; Sciacovelli L
    Clin Biochem; 1996 Feb; 29(1):67-72. PubMed ID: 8929827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
    Kobayashi Y; Ochi M; Tokue A
    Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.